No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback